Rowasa
PHONETIC PRONUNCIATION: Rowasa
Description
Rowasa: Uses, Dosage, Demographic, Side Effects, Interactions, and Generic Options Rowasa (mesalamine) is an anti-inflammatory medication that is used to treat mild to moderate ulcerative colitis. The medication works by reducing inflammation in the lining of the colon and rectum. In this article, we will explore the uses, dosage, demographic, possible side effects, interactions, and generic options of Rowasa. Uses Rowasa is primarily indicated for the treatment of ulcerative colitis, a chronic inflammatory bowel disease that affects the lining of the rectum and colon. The medication helps to ease the symptoms of ulcerative colitis including diarrhea, abdominal pain, rectal bleeding, and urgency to defecate. Rowasa is not a cure for ulcerative colitis but it can help improve the quality of life of patients living with the condition. Dosage The dosage of Rowasa will depend on the severity of the disease and the age of the patient. The medication is available in an enema form that is inserted into the rectum for 30 minutes for maximum absorption. The recommended dose is 1 enema (4 g) once daily at bedtime for 3 to 6 weeks. The duration of treatment may extend up to 8 weeks in some cases. Always follow your doctor's instructions for your specific dosage. Demographic Rowasa is indicated for use in adults above the age of 18 years. Although the medication is not recommended for use in children, it may be used in certain cases under the guidance of a healthcare provider. Patients with a history of kidney or liver disease should consult their doctor before taking Rowasa. Side Effects Like any medication, Rowasa may cause side effects in some patients. The most common side effects of Rowasa include: - Diarrhea - Headache - Nausea and vomiting - Abdominal pain - Dizziness - Rectal pain or discomfort - Skin rash and itching Serious side effects of Rowasa are rare but may include: - Severe allergic reactions - Blood disorders - Kidney problems - Liver problems Patients experiencing any of these adverse effects should contact their doctor immediately. Interactions Rowasa may interact with other medications, supplements, or herbal products. It is important to tell your doctor about all the drugs you are taking to avoid potential interactions. Some of the drugs that may interact with Rowasa include: - Azathioprine - Mercaptopurine - Warfarin - Phenobarbital - Phenytoin - Sulfa drugs Generic Options The generic name for Rowasa is mesalamine. The medication is available under various brand names, including Pentasa, Asacol, Lialda, and Delzicol. Generic versions of mesalamine are also available in various strengths and formulations. Conclusion Rowasa is an effective medication for the treatment of ulcerative colitis. The medication can help improve the quality of life of patients by reducing the symptoms associated with the disease. However, as with any medication, Rowasa may cause side effects and may interact with other drugs. Patients should always follow their doctor's instructions and report any adverse effects. The generic options of Rowasa can also be considered as they may be more affordable than the brand name medication.
Faq for Rowasa
Rowasa is used to treat mild to moderate ulcerative colitis, a condition that causes inflammation and sores in the colon and rectum.
Rowasa is a type of medication called a 5-aminosalicylate, which works by reducing the inflammation in the colon and rectum and preventing flare-ups of ulcerative colitis.
Rowasa is usually used as an enema, which is inserted into the rectum and should be held for about 30 minutes. The recommended dosage and frequency will be determined by your healthcare provider.
Common side effects of Rowasa may include headache, nausea, diarrhea, abdominal pain, fever, and rash. If you experience severe side effects or any allergic reactions, seek immediate medical attention.
It is important to discuss the use of Rowasa with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding, as its safety during these periods has not been adequately studied.
The effectiveness of Rowasa may vary from person to person. Some people may start experiencing improvements in symptoms within 3 to 6 weeks of starting treatment, while others may take longer.
Rowasa may interact with certain medications, such as anticoagulants (blood thinners) and other 5-aminosalicylates. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions.
Rowasa should be stored at room temperature, away from light and moisture. Be sure to follow the specific storage instructions provided by your pharmacist.
Rowasa is approved for use in adults, but its safety and effectiveness in children have not been established. The use of Rowasa in children should be determined by a healthcare professional.